Wednesday, September 23, 2026

Medical Properties Trust, Inc. And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Medical Properties Trust, Inc. And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. FirstService Corporation

7.6% sales growth and 15.07% return on equity

FirstService Corporation, together with its subsidiaries, provides residential property services to residential and commercial customers in the United States and Canada.

FirstService Corporation's sales growth this year is anticipated to be 7.6% and 6.5% for next year.

Year-on-year quarterly revenue growth grew by 14.7%, now sitting on 2.77B for the twelve trailing months.

FirstService Corporation's sales growth for the next quarter is 7.6%. The company's growth estimates for the current quarter and the next is 47.1% and 31.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.07%.

Volatility

FirstService Corporation's last day, last week, and last month's current volatility was 1.06%, 1.12%, and 1.38%, respectively.

FirstService Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.29% (day), 1.95% (last week), and 2.35% (last month), respectively.

FirstService Corporation's Stock Yearly Top and Bottom Value

FirstService Corporation's stock is valued at $163.39 at 20:22 EST, under its 52-week high of $164.40 and way above its 52-week low of $74.45.

FirstService Corporation's Moving Average

FirstService Corporation's value is higher than its 50-day moving average of $150.80 and way above its 200-day moving average of $139.26.

3. Medical Properties Trust, Inc.

22% sales growth and 6.01% return on equity

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities.

Medical Properties Trust, Inc.'s sales growth this year is expected to be 16.5% and 7.3% for next year.

Year-on-year quarterly revenue growth grew by 29.9%, now sitting on 1.27B for the twelve trailing months.

Medical Properties Trust, Inc.'s sales growth for the next quarter is 22%. The company's growth estimates for the ongoing quarter and the next is 80% and 28.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.01%.

Volatility

Medical Properties Trust, Inc.'s last day, last week, and last month's current volatility was 1.10%, 0.52%, and 0.78%, respectively.

Medical Properties Trust, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.46% (day), 1.30% (last week), and 1.87% (last month), respectively.

Medical Properties Trust, Inc.'s Stock Yearly Top and Bottom Value

Medical Properties Trust, Inc.'s stock is valued at $22.14 at 20:22 EST, under its 52-week high of $22.75 and way above its 52-week low of $15.30.

Medical Properties Trust, Inc.'s Moving Average

Medical Properties Trust, Inc.'s value is above its 50-day moving average of $21.54 and higher than its 200-day moving average of $20.25.

4. PetMed Express, Inc.

9.5% sales growth and 23.08% return on equity

PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States.

PetMed Express, Inc.'s sales growth this year is anticipated to be 9.7% and 3.2% for next year.

Year-on-year quarterly revenue growth grew by 10%, now sitting on 311.82M for the twelve trailing months.

PetMed Express, Inc.'s sales growth for the next quarter is 9.5%. The company's growth estimates for the present quarter and the next is 14.3% and 15.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.08%.

Volatility

PetMed Express, Inc.'s last day, last week, and last month's current volatility was 0.22%, 0.88%, and 2.02%, respectively.

PetMed Express, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.95% (day), 3.62% (last week), and 4.28% (last month), respectively.

PetMed Express, Inc.'s Stock Yearly Top and Bottom Value

PetMed Express, Inc.'s stock is valued at $32.47 at 20:22 EST, way under its 52-week high of $57.00 and way higher than its 52-week low of $27.67.

PetMed Express, Inc.'s Moving Average

PetMed Express, Inc.'s value is below its 50-day moving average of $34.04 and under its 200-day moving average of $32.77.

5. Ituran Location and Control Ltd.

21.5% sales growth and 13.05% return on equity

Ituran Location and Control Ltd., together with its subsidiaries, provides location-based services and wireless communications products.

Ituran Location and Control Ltd.'s sales growth this year is anticipated to be 11.5% and 12.2% for next year.

Year-on-year quarterly revenue growth declined by 2.9%, now sitting on 245.63M for the twelve trailing months.

Ituran Location and Control Ltd.'s sales growth for the next quarter is 21.5%. The company's growth estimates for the present quarter and the next is 22.6% and 14.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.05%.

Volatility

Ituran Location and Control Ltd.'s last day, last week, and last month's current volatility was 1.36%, 1.09%, and 1.76%, respectively.

Ituran Location and Control Ltd.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.52% (day), 2.77% (last week), and 3.86% (last month), respectively.

Ituran Location and Control Ltd.'s Stock Yearly Top and Bottom Value

Ituran Location and Control Ltd.'s stock is valued at $21.39 at 20:22 EST, way below its 52-week high of $23.86 and way above its 52-week low of $12.52.

Ituran Location and Control Ltd.'s Moving Average

Ituran Location and Control Ltd.'s worth is below its 50-day moving average of $21.87 and way higher than its 200-day moving average of $18.58.

6. Ecolab Inc.

16% sales growth and 13.19% return on equity

Ecolab Inc. provides water, hygiene, and energy technologies and services worldwide.

Ecolab Inc.'s sales growth this year is expected to be 5.9% and 6.6% for next year.

Year-on-year quarterly revenue growth declined by 5.5%, now sitting on 11.79B for the twelve trailing months.

Ecolab Inc.'s sales growth for the next quarter is 16%. The company's growth estimates for the present quarter and the next is a negative 19% and 92.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.19%.

Volatility

Ecolab Inc.'s last day, last week, and last month's current volatility was 1.48%, 0.67%, and 0.80%, respectively.

Ecolab Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.09% (day), 0.93% (last week), and 1.83% (last month), respectively.

Ecolab Inc.'s Stock Yearly Top and Bottom Value

Ecolab Inc.'s stock is valued at $223.15 at 20:22 EST, under its 52-week high of $231.36 and way above its 52-week low of $158.13.

Ecolab Inc.'s Moving Average

Ecolab Inc.'s worth is above its 50-day moving average of $211.22 and higher than its 200-day moving average of $210.00.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com